Clinical and Neuroimaging Features in Charcot-Marie-Tooth Patients with GDAP1 Mutations
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose Mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) are known to cause Charcot-Marie-Tooth disease (CMT). These mutations are very rare in most countries, but not in certain Mediterranean countries. The purpose of this study was to identify the clinical and neuroimaging characteristics of Korean CMT patients with GDAP1 mutations. Methods Gene sequencing was applied to 1,143 families in whom CMT had been diagnosed from 2005 to 2020. PMP22 duplication was found in 344 families, and whole-exome sequencing was performed in 699 patients. Magnetic resonance imaging (MRI) were obtained using either a 1.5-T or 3.0-T MRI system. Results We found ten patients from eight families with GDAP1 mutations: five with autosomal dominant (AD) CMT type 2K (three families with p.R120W and two families with p.Q218E) and three with autosomal recessive (AR) intermediate CMT type A (two families with homozygous p.H256R and one family with p.P111H and p.V219G mutations). The frequency was about 1.0% exclusive of the PMP22 duplication, which is similar to that in other Asian countries. There were clinical differences among AD GDAP1 patients according to mutation sites. Surprisingly, fat infiltrations evident in lower-limb MRI differed between AD and AR patients. The posterior-compartment muscles in the calf were affected early and predominantly in AD patients, whereas AR patients showed fat infiltration predominantly in the anterolateral-compartment muscles. Conclusions This is the first cohort report on Korean patients with GDAP1 mutations. The patients with AD and AR inheritance routes exhibited different clinical and neuroimaging features in the lower extremities. We believe that these results will help to expand the knowledge of the clinical, genetic, and neuroimaging features of CMT.
Abstract
Background and Purpose Mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) are known to cause Charcot-Marie-Tooth disease (CMT). These mutations are very rare in most countries, but not in certain Mediterranean countries. The purpose of this study was to identify the clinical and neuroimaging characteristics of Korean CMT patients with GDAP1 mutations. Methods Gene sequencing was applied to 1,143 families in whom CMT had been diagnosed from 2005 to 2020. PMP22 duplication was found in 344 families, and whole-exome sequencing was performed in 699 patients. Magnetic resonance imaging (MRI) were obtained using either a 1.5-T or 3.0-T MRI system. Results We found ten patients from eight families with GDAP1 mutations: five with autosomal dominant (AD) CMT type 2K (three families with p.R120W and two families with p.Q218E) and three with autosomal recessive (AR) intermediate CMT type A (two families with homozygous p.H256R and one family with p.P111H and p.V219G mutations). The frequency was about 1.0% exclusive of the PMP22 duplication, which is similar to that in other Asian countries. There were clinical differences among AD GDAP1 patients according to mutation sites. Surprisingly, fat infiltrations evident in lower-limb MRI differed between AD and AR patients. The posterior-compartment muscles in the calf were affected early and predominantly in AD patients, whereas AR patients showed fat infiltration predominantly in the anterolateral-compartment muscles. Conclusions This is the first cohort report on Korean patients with GDAP1 mutations. The patients with AD and AR inheritance routes exhibited different clinical and neuroimaging features in the lower extremities. We believe that these results will help to expand the knowledge of the clinical, genetic, and neuroimaging features of CMT.
참고문헌 (26)
- Madrid R, "The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies. Part 2. Observations on pathological changes in sural nerve biopsies", J Neurol Sci, 32, pp.91~122 (1977)
- Rossor AM, "Clinical implications of genetic advances in Charcot-Marie-Tooth disease", Nat Rev Neurol, 9, pp.562~571 (2013)
- Baxter RV, "Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A", 8q21, 2002, pp.30, 21~22
- Claramunt R, "Genetics of Charcot-Marie-Tooth disease type 4A : mutations, inheritance, phenotypic variability, and founder effect", J Med Genet, 42, pp.358~365 (2005)
- Cuesta A, "The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease", Nat Genet, 30, pp.22~25 (2002)
- Senderek J, "Mutations in the ganglioside-induced differentiationassociated protein-1(GDAP1)gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy", Brain, 126, pp.642~649 (2003)
- DiVincenzo C, "The allelic spectrum of Charcot-Marie-Tooth disease in over 17, 000 individuals with neuropathy", Mol Genet Genomic Med, 2, pp.522~529 (2014)
- Yoshimura A, "Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan", J Neurol Neurosurg Psychiatry, 90, pp.195~202 (2019)
- Pakhrin PS, "Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations", J Neurol, 265, pp.637~646 (2018)
- Sivera R, "Charcot-Marie-Tooth disease : genetic and clinical spectrum in a Spanish clinical series", Neurology, 81, pp.1617~1625 (2013)
- Manganelli F, "Charcot-Marie-Tooth disease : frequency of genetic subtypes in a Southern Italy population", J Peripher Nerv Syst, 19, pp.292~298 (2014)
- Cornett KMD, "Magnetic resonance imaging of the anterior compartment of the lower leg is a biomarker for weakness, disability, and impaired gait in childhood Charcot-Marie-Tooth disease", Muscle Nerve, 59, pp.213~217 (2019)
- Juras V, "Magnetic resonance imaging of the musculoskeletal system at 7t : morphological imaging and beyond", Top Magn Reson Imaging, 28, pp.125~135 (2019)
- Sivera R, "Distribution and genotype-phenotype correlation of GDAP1mutations in Spain", Sci Rep, 7, pp.6677~ (2017)
- Sivera R, "Phenotypical features of the p. R120W mutation in the GDAP1gene causing autosomal dominant Charcot-Marie-Tooth disease", J Peripher Nerv Syst, 15, pp.334~344 (2010)
- Chung KW, "Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A", Neuromuscul Disord, 18, pp.610~618 (2008)
- Birouk N, "X-linked Charcot-Marie-Tooth disease with connexin 32 mutations : clinical and electrophysiologic study", Neurology, 50, pp.1074~1082 (1998)
- Sadjadi R, "Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score(CMTNSv2)second version, using Rasch analysis", J Peripher Nerv Syst, 19, pp.192~196 (2014)
- Goutallier D, "Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan", Clin Orthop Relat Res, pp.78~83 (1994)
- Chung KW, "A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease", J Hum Genet, 53, pp.360~364 (2008)
- Choi BO, "Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease", Hum Mutat, 33, pp.1610~1615 (2012)
- Chung KW, "Two recessive intermediate Charcot-Marie-Tooth patients with GDAP1 mutations", J Peripher Nerv Syst, 16, pp.143~146 (2011)
- Murphy SM, "Charcot-Marie-Tooth disease : frequency of genetic subtypes and guidelines for genetic testing", J Neurol Neurosurg Psychiatry, 83, pp.706~710 (2012)
- Gess B, "Charcot-Marie-Tooth disease : frequency of genetic subtypes in a German neuromuscular center population", Neuromuscul Disord, 23, pp.647~651 (2013)
- Auranen M, "Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland", Neurogenetics, 14, pp.123~132 (2013)
- Fu J, "Similar clinical, pathological, and genetic features in Chinese patients with autosomal recessive and dominant Charcot-Marie-Tooth disease type 2K", Neuromuscul Disord, 27, pp.760~765 (2017)